´ EKOS Corporation pioneered the development and the clinical application of ultrasound accelerated thrombolysis, introducing its first system for the treatment of vascular thrombosis in 2005 ´ EKOS enables faster, safer and more complete dissolution of clot ´ Current leader in the peripheral vascular market with significant near-term market opportunity in the pulmonary embolism market and development program ongoing for hemorrhagic stroke